The Effect of Paedfusor TCI, Eleveld TCI, and Sevoflurane Anesthesia on Postoperative Awakening Agitation in Pediatric Patients
Key facts
- Who runs it
- Marmara University Pendik Training and Research Hospital
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 13 Jan 2026
- Expected to end
- 30 Nov 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- propofol ( Paedfusor Model)
- propofol (Eleveld Model)
- Sevofluorane
- Record updated
- 16 April 2026
Who can take part
- Age
- 3 years to 10 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Children aged 3-10 years
- Children weighing over 10 kg
- American Society of Anesthesiologists (ASA) physical condition classification I-II
- Those who will undergo planned urogenital surgery under general anesthesia
- Those who have obtained written informed consent from their parents or legal guardians
Who cannot take part
- Use of sedatives or psychoactive drugs
- History of previous adverse reactions to anesthesia
- Patients requiring emergency surgery
- Known neurological or psychiatric disorders
- Developmental delay or cognitive impairment
- Allergy or contraindication to the study drugs (propofol or sevoflurane)
- Significant liver, kidney, or cardiovascular disease
- Patients assessed as ASA III or higher
- Patients whose parents or legal guardians have not given consent
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 3 and 10 years old?
This trial is currently available in Türkiye.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Emergence delirium is a common complication in pediatric patients undergoing general anesthesia. The aim of this study is to investigate the incidence of postoperative awakening delirium and agitation in pediatric patients aged 3-10 years (ASA I-II) using two different target-controlled infusion (TCI) methods (Paedfusor and Eleveld) for TIVA, compared to inhalation anesthesia. This study will examine the effect of two different TCI models on postoperative awakening agitation/delirium by comparing them with each other and with inhalation anesthesia.
The 3 groups in the trial
- Paedfusor GroupTreatment being tested
Anesthesia will be maintained using propofol with target-controlled infusion based on the Paedfusor pharmacokinetic model.
Treatment: propofol ( Paedfusor Model)
- Eleveld GroupTreatment being tested
Anesthesia will be maintained using propofol with target-controlled infusion based on the Eleveld pharmacokinetic model.
Treatment: propofol (Eleveld Model)
- Sevoflurane GroupExisting treatment, for comparison
Anesthesia will be maintained using sevoflurane inhalational anesthesia.
Treatment: Sevofluorane
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Investigation of the Effects of Two Different TCI (Target Controlled Infusion) Models (Paedfusor and Eleveld) and Inhalation Anesthesia on Postoperative Awakening Agitation/Delirium in Pediatric Patients
- Criteria questions
- Built from NCT07534956, who can take part
- Record updated
- 16 April 2026